Combination therapy with galantamine and memantine improves behavioral and psychological symptoms of dementia (BPSD) in patients with early-onset Alzheimer's disease

Australian and New Zealand Journal of Psychiatry

Volumn 47, Issue 6, 2013, Pages 583-

  Hamuro, Atsushi ^a  

^a Amekudai Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; GALANTAMINE; MEMANTINE;

ADD ON THERAPY; ADULT; ALZHEIMER DISEASE; BEHAVIOR DISORDER; BEHAVIORAL AND PSYCHOLOGICAL SYMPTOM OF DEMENTIA; CASE REPORT; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; IRRITABILITY; LETTER; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NOISE REDUCTION; PRESCRIPTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VIOLENCE;

ALZHEIMER DISEASE; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GALANTAMINE; HUMANS; MEMANTINE; MIDDLE AGED; PARASYMPATHOMIMETICS;

EID: 84880561892     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867412464718     Document Type: Letter

References (2)

1. Geerts H and Grossberg GT (2006) Pharmacology of acetylcholinesterase inhibitors and N-methyld-aspartate receptors for combination therapy in the treatment of Alzheimer's disease. Journal of Clinical Pharmacology 46: 8S-16S.
2. Jensen AA, Frølund B, Liljefors T, et al. (2005) Neuronal nicotinic acetylcholine receptors: Structural revelations, target identifications, and therapeutic inspirations. Journal of Medicinal Chemistry 48: 4705-4745.